Your only mesothelioma survival news source! Click on each item to read full story.   California Mesothelioma Attorney Says New “Orphan Drug” Shows Promise For Treating Asbestos Cancer read story Jack Clapper is an expert asbestos and mesothelioma attorney and founder of one of the first mesothelioma law firms in California, Clapper Patti Schweizer & Mason (CPSM), which specializes in representing those injured by asbestos. Having been in the field for over three decades, Clapper and his firm not only understands the complexities of asbestos litigation and bankruptcy trust claims, but ...   Biomarkers - Technologies, Markets and Companies read story NEW YORK, Feb. 1, 2012  /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Biomarkers - Technologies,markets and companies http://www.reportlinker.com/p0203536/Biomarkers---Technologiesmarkets-and-companies.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=GenomicsThis ...   UH Case Medical Center Offers New Therapy for Gynecologic Cancer Patients read story CLEVELAND, Jan. 20, 2012 /PRNewswire/ -- Patients with gynecologic cancer have new hope in a novel technology now offered at the Seidman Cancer Center at University Hospitals (UH) Case Medical Center.  ...   Polaris Group Doses First Patient in Phase 1 Clinical Trial of Lead Therapeutic Candidate ADI-PEG 20 in Combination ... read story SAN DIEGO , Jan. 10, 2012 /PRNewswire/ -- Polaris Group (Polaris) today announced that it has dosed the first patient in a Phase 1 clinical trial evaluating its lead cancer therapeutic, pegylated arginine ...   This Week in the Journal of Clinical Pathology read story Silke Lassmann and her colleagues at the University Medical Center in Freiburg, Germany, report in the Journal of Clinical Pathology that Aurora-B protein expression is common in serous, FIGO stage III ovarian carcinomas.   ‘We’re here to make other people’s lives easier’ read story Many people avert their eyes when they walk by the homeless. Hanne Mintz opens her hand, her heart and her home.   UHCMC now offers HITEC for women with gynecologic cancers read story Patients with gynecologic cancer have new hope in a novel technology now offered at the Seidman Cancer Center at University Hospitals (UH) Case Medical Center. A team of cancer specialists, led by Robert DeBernardo, MD, is among the first in the nation to launch a dedicated program using Hyperthermic Intraperitoneal Chemotherapy (HIPEC) to treat ovarian, endometrial and select other cancers.